Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community perspectives on the return of research results and ownership of data and specimens for brain tumor genomic research.

SSM. Qualitative research in health·2026
Same author

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Nature·2026
Same author

Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step?

Neuro-oncology·2026
Same author

TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.

Cell reports. Medicine·2026
Same author

Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.

Neuro-oncology·2025
Same author

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Neuro-oncology·2025
Same journal

High-throughput DNA engineering by mating bacteria.

Cell systems·2026
Same journal

Living bacterial reservoir computers for information processing and sensing.

Cell systems·2026
Same journal

A data-driven modeling framework for mapping genotypes to synthetic microbial community functions.

Cell systems·2026
Same journal

BulkFormer: A large-scale foundation model for bulk transcriptomes.

Cell systems·2026
Same journal

Glycoform engineering of a mammalian platform to sculpt a humanized recombinant bioscavenger.

Cell systems·2026
Same journal

Targeted genomic editing of human gut Bacteroides species based on CRISPR-associated transposases.

Cell systems·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Navigating the Cancer Transcriptome by Decoding Divergent Oncogenic States.

Samirkumar B Amin1, Roel G W Verhaak1

  • 1The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.

Cell Systems
|August 25, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method to break down abnormal cell signaling caused by cancer mutations. This approach identifies fundamental cell states that could improve cancer treatment effectiveness.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.0K
Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

12.8K

Related Experiment Videos

Last Updated: Feb 24, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.0K
Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

12.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Aberrant signaling pathways are hallmarks of cancer, driven by oncogenic mutations.
  • Understanding the cellular consequences of these mutations is crucial for developing targeted therapies.

Purpose of the Study:

  • To develop a new framework for analyzing oncogenic signaling.
  • To identify core cellular states influenced by oncogenic mutations.
  • To assess the potential of these states for therapeutic targeting.

Main Methods:

  • Decomposition of aberrant signaling networks.
  • Identification of distinct cellular states.
  • Correlation analysis between cellular states and therapeutic response.

Main Results:

  • Oncogenic signaling can be systematically decomposed into fundamental cellular states.
  • These identified states represent distinct biological contexts.
  • Certain cellular states show increased permissiveness to specific therapeutic interventions.

Conclusions:

  • A novel approach to dissect oncogenic signaling provides new insights into cancer biology.
  • The identified core cellular states offer a refined perspective for predicting therapeutic efficacy.
  • This framework may guide the development of more personalized and effective cancer treatments.